Prenatal diagnostic tests are at times essential to make sure that the fetus is developing ordinarily and is healthy though inside the uterus. Analysis of motherly or fetal conditions permits timely treatment and/or exceptional preparations to care for both mother and baby in the course of pregnancy, delivery, and post-partum.
Adroit Market Research study on the global market for prenatal diagnostics offers a holistic view of the industry from 2020 to 2028 as forecast period, including factors such as market drivers, limitations, opportunities, threats and regulatory overview. The market has been analyzed from 2018 to 2028, with a base year estimate of 2020 and a projection from 2021 to 2028. The report covers the current status and potential characteristics of the market at both the global and the country level. Moreover, the report also assesses market competition with Porter's analysis of five strengths and places leading players on the basis of their product range, regional presence, strategic initiatives and overall sales. Prominent players in the global prenatal diagnostics market have been analyzed in depth.
The leading cause of neonatal morbidity and mortality in high- and middle-income countries is preterm birth, commonly defined as birth prior to 37 weeks gestation. Preterm birth is associated with high economic and emotional costs. It is hoped that identifying those at high risk through the use of biomarkers would allow the targeting of future research and interventions to those most likely to benefit. Recent technical advances combined with concerns regarding the risks and limitations associated with traditional diagnostic approaches have led to dramatic changes in the often controversial field of prenatal diagnostics. Despite improvements in maternal survival rates, there remain improvements to be made. Biomarkers to allow prenatal diagnosis of potential fatal conditions for both mother and baby will be key to future developments.
The key players of global prenatal diagnostics market report include Laboratory Corporation of America Holdings, Quest Diagnostics, Sequenom, Illumina, Inc., Ariosa Diagnostics, GeneDx., Natera, Inc., Ravgen, Eurofins NTD Inc., Counsyl, Inc., PREMAITHA HEALTH among others.
Key Segments of the Global Prenatal Diagnostics Market
Test Type Overview, 2018-2028 (USD Million)
- MaterniT21 PLUS
Regional Overview, 2018-2028 (USD Million)
- Rest of Europe
- Rest of Asia-Pacific
Middle East and Africa